Patents by Inventor Abdelilah Wakkach

Abdelilah Wakkach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for obtaining antigen-specific Tr1 regulatory lymphocytes
    Patent number: 8076133
    Abstract: The invention relates to a method for preparing antigen-specific Tr1 regulatory lymphocytes. The inventive method involves the use of artificial antigen-presenting cells expressing a molecule from the HLA class II system and a human LFA-3 molecule and expressing none of the B7-1, B7-2, B7-H1, CD40, CD23, or ICAM-1 costimulatory molecules.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: December 13, 2011
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Hervé Groux, Françoise Cottrez, Abdelilah Wakkach
  • Composition for treating cancer adapted for intra-tumoral administration and uses thereof
    Patent number: 7888320
    Abstract: A composition is adapted for intra-tumoral administration of a subject suffering from cancer, whereby administration of the composition to the subject induces IMC differentiation by neutralizing a factor implicated in a DC differentiation defect.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: February 15, 2011
    Assignee: Centre National de la Recherche Scientifique - CNRS
    Inventors: Abdelilah Wakkach, Claudine Blin-Wakkach, David Momier, Georges Carle
  • Composition for treating cancer adapted for intra-tumoral administration and uses thereof
    Publication number: 20090148452
    Abstract: A composition is adapted for intra-tumoral administration of a subject suffering from cancer, whereby administration of the composition to the subject induces IMC differentiation by neutralizing a factor implicated in a DC differentiation defect.
    Type: Application
    Filed: April 14, 2006
    Publication date: June 11, 2009
    Applicant: Centre National de la Recherche Scientifique-CNRS an organization of France,
    Inventors: Abdelilah Wakkach, Claudine Blin-Wakkach, David Momier, Georges Carle
  • METHOD FOR OBTAINING ANTIGEN-SPECIFIC TR1 REGULATORY LYMPHOCYTES
    Publication number: 20080233095
    Abstract: The invention relates to a method for preparing antigen-specific Tr1 regulatory lymphocytes. The inventive method involves the use of artificial antigen-presenting cells, expressing a molecule from the HLA class II system and a human LFA-3 molecule and expressing none of the B7-1, B7-2, B7-H1, CD40, CD23 or ICAM-1 costimulation molecules.
    Type: Application
    Filed: October 30, 2007
    Publication date: September 25, 2008
    Applicant: INSTITUT NATIONAL DE LA SANTE DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Herve GROUX, Francoise Cottrez, Abdelilah Wakkach
  • Method for obtaining antigen-specific tr1 regulatory lymphocytes
    Publication number: 20040191235
    Abstract: The invention relates to a method for preparing antigen-specific Tr1 regulatory lymphocytes. The inventive method involves the use of artificial antigen-presenting cells, expressing a molecule from the HLA class II system and a human LFA-3 molecule and expressing none of the B7-1, B7-2, B7-H1, CD40, CD23 or ICAM-1 costimulation molecules.
    Type: Application
    Filed: June 1, 2004
    Publication date: September 30, 2004
    Inventors: Herve Groux, Francoise Cottrez, Abdelilah Wakkach